Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIOW) Cash & Current Investments (2021 - 2025)

Historic Cash & Current Investments for Cardio Diagnostics Holdings (CDIOW) over the last 5 years, with Q3 2025 value amounting to $6.4 million.

  • Cardio Diagnostics Holdings' Cash & Current Investments rose 22055.13% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year increase of 22055.13%. This contributed to the annual value of $7.8 million for FY2024, which is 50984.39% up from last year.
  • Cardio Diagnostics Holdings' Cash & Current Investments amounted to $6.4 million in Q3 2025, which was up 22055.13% from $8.0 million recorded in Q2 2025.
  • Cardio Diagnostics Holdings' Cash & Current Investments' 5-year high stood at $74.7 million during Q2 2022, with a 5-year trough of $9681.0 in Q3 2021.
  • For the 5-year period, Cardio Diagnostics Holdings' Cash & Current Investments averaged around $18.8 million, with its median value being $5.7 million (2023).
  • As far as peak fluctuations go, Cardio Diagnostics Holdings' Cash & Current Investments soared by 76983483.11% in 2022, and later crashed by 9513.04% in 2023.
  • Quarter analysis of 5 years shows Cardio Diagnostics Holdings' Cash & Current Investments stood at $65.5 million in 2021, then tumbled by 93.71% to $4.1 million in 2022, then plummeted by 68.83% to $1.3 million in 2023, then soared by 509.84% to $7.8 million in 2024, then dropped by 18.81% to $6.4 million in 2025.
  • Its last three reported values are $6.4 million in Q3 2025, $8.0 million for Q2 2025, and $9.7 million during Q1 2025.